Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens

Autor: Maarten J. Postma, Ajp Boeke, Igm van Valkengoed, Lex M. Bouter, Servaas A. Morré, Ajc van den Brule, C. J. L. M. Meijer

Publikováno v: van Valkengoed, I G M, Postma, M J, Morre, S A, van den Brule, A J C, Meijer, C J L M, Bouter, L M & Boeke, A J P 2001, ' Cost effectiveness analysis of a population based screening programme for asymptomatic Chlamydia trachomatis infections in women by means of home obtained urine specimens ', Sexually Transmitted Infections, vol. 77, no. 4, pp. 276-282 . https://doi.org/10.1136/sti.77.4.276
Sexually Transmitted Infections, 77(4), 276-282. BMJ Publishing Group
University of Groningen
Sexually Transmitted Infections, 77(4), 276-282. BMJ PUBLISHING GROUP
Sexually transmitted infections, 77(4), 276-282. BMJ Publishing Group

Objectives: To evaluate the cost effectiveness of a systematic screening programme for asymptomatic Chlamydia, trachomatis infections in a female inner city population. To determine the sensitivity of the cost effectiveness analysis to variation in t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::65d439fa87cadcd4ab2d24e165577815
https://research.vu.nl/en/publications/9964711a-7118-45dd-86ad-1a5e9eca30e4

Perspective of obstetric care-providers on being involved in cervical cancer screening during antenatal care in the Netherlands.

Autor: van der Hoeven NMA; Department of Gynaecological Oncology, University Medical Centre Rotterdam, Rotterdam, the Netherlands., van den Brule AJC; Department of Pathology, Jeroen Bosch Hospital, 's-Hertogenbosch, the Netherlands., van Beekhuizen HJ; Department of Gynaecological Oncology, University Medical Centre Rotterdam, Rotterdam, the Netherlands., de Kok IMCM; Department of Public Health, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, the Netherlands., van Kemenade FJ; Department of Pathology, University Medical Centre Rotterdam, Rotterdam, the Netherlands.

Publikováno v: Cancer medicine [Cancer Med] 2024 Jul; Vol. 13 (13), pp. e7380.

Reclassification of diffuse large B cell lymphoma to large B cell lymphoma with IRF4 rearrangement in an adult population.

Autor: Hesius EAM; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., van Laar L; Pathology-DNA, Rijnstate Hospital, Arnhem, the Netherlands.; Pathology-DNA, St Antonius Hospital, Nieuwegein, the Netherlands., Oosterveld M; Department of Hematology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands., van Spriel AB; Department of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Radboud University Medical Center, Nijmegen, the Netherlands., Scheijen B; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Leeuwis JW; Pathology-DNA, Rijnstate Hospital, Arnhem, the Netherlands., Marres HAM; Department of Otorhinolaryngology and Head and Neck Surgery, Radboud University Medical Center, Nijmegen, the Netherlands., Groenen PJTA; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., Stevens WBC; Department of Hematology, Radboud University Medical Center, Nijmegen, the Netherlands., van der Spek E; Department of Hematology, Rijnstate Hospital, Arnhem, the Netherlands., van den Brule AJC; Pathology-DNA, Jeroen Bosch Hospital, Den Bosch, the Netherlands., Hoevenaars BM; Department of Pathology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands., Hebeda KM; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands., van den Brand M; Pathology-DNA, Rijnstate Hospital, Arnhem, the Netherlands.; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.

Publikováno v: Histopathology [Histopathology] 2023 Jun; Vol. 82 (7), pp. 1013-1020. Date of Electronic Publication: 2023 Mar 05.

Sociodemographic Characteristics and Screening Outcomes of Women Preferring Self-Sampling in the Dutch Cervical Cancer Screening Programme: A Population-Based Study.

Autor: Aitken CA; University Medical Center Rotterdam, Erasmus MC, Department of Public Health, Rotterdam, the Netherlands.; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Inturrisi F; Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, the Netherlands.; Amsterdam Public Health, Methodology, Amsterdam, the Netherlands., Kaljouw S; University Medical Center Rotterdam, Erasmus MC, Department of Public Health, Rotterdam, the Netherlands., Nieboer D; University Medical Center Rotterdam, Erasmus MC, Department of Public Health, Rotterdam, the Netherlands., Siebers AG; The Nationwide Network and Registry of Histo-and Cytopathology in the Netherlands (PALGA Foundation), Houten, the Netherlands., Melchers WJG; Radboud University Medical Center, Medical Microbiology, Nijmegen, the Netherlands., van den Brule AJC; Jeroen Bosch Hospital, Pathologie-DNA, 's-Hertogenbosch, the Netherlands., Molijn A; DDL Diagnostic Laboratory, NMDL-LCPL, Rijswijk, the Netherlands., Hinrichs JWJ; Symbiant Pathology Expert Centre Hoorn, Hoorn, the Netherlands.; Pathology, University Medical Center Utrecht, Utrecht, the Netherlands., Niesters HGM; Division of Clinical Virology, Department of Medical Microbiology, The University of Groningen, University Medical Center Groningen, Groningen, the Netherlands., van Kemenade FJ; Department of Pathology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, the Netherlands., Berkhof J; Amsterdam UMC location Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam, the Netherlands.; Amsterdam Public Health, Methodology, Amsterdam, the Netherlands., de Kok IMCM; University Medical Center Rotterdam, Erasmus MC, Department of Public Health, Rotterdam, the Netherlands.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2023 Feb 06; Vol. 32 (2), pp. 183-192.

Clinical performance of high-risk HPV testing on self-samples versus clinician samples in routine primary HPV screening in the Netherlands: An observational study.

Autor: Inturrisi F; Amsterdam UMC, Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam Public Health, 1081 HV Amsterdam, Netherlands., Aitken CA; Erasmus MC University Medical Center, Public Health, 3015 GD Rotterdam, Netherlands.; Erasmus MC University Medical Center, Pathology, 3015 GD Rotterdam, Netherlands., Melchers WJG; Radboud University Medical Center, Medical Microbiology, 6525 GA Nijmegen, Netherlands., van den Brule AJC; Jeroen Bosch Hospital, Pathologie-DNA, 5223 GZ 's-Hertogenbosch, Netherlands., Molijn A; NMDL-LCPL, 2280 CA Rijswijk, Netherlands., Hinrichs JWJ; Symbiant Pathology Expert Centre Hoorn, 1624 NP Hoorn, Netherlands., Niesters HGM; University Medical Center Groningen, University of Groningen, Medical Microbiology, 9713 GZ Groningen, Netherlands., Siebers AG; PALGA, 3991 SZ Houten, Netherlands., Schuurman R; University Medical Center Utrecht, Medical Microbiology, 3584 CX Utrecht, Netherlands., Heideman DAM; Amsterdam UMC, Vrije Universiteit Amsterdam, Pathology, Cancer Center Amsterdam, 1081 HV Amsterdam, Netherlands., de Kok IMCM; Erasmus MC University Medical Center, Public Health, 3015 GD Rotterdam, Netherlands., Bekkers RLM; GROW School for Oncology and Developmental Biology, Maastricht University, 6229 ER Maastricht, Netherlands.; Catharina Hospital, 5623 EJ Eindhoven, Netherlands., van Kemenade FJ; Erasmus MC University Medical Center, Pathology, 3015 GD Rotterdam, Netherlands., Berkhof J; Amsterdam UMC, Vrije Universiteit Amsterdam, Epidemiology and Data Science, Amsterdam Public Health, 1081 HV Amsterdam, Netherlands.

Publikováno v: The Lancet regional health. Europe [Lancet Reg Health Eur] 2021 Nov 09; Vol. 11, pp. 100235. Date of Electronic Publication: 2021 Nov 09 (Print Publication: 2021).